Document is current
Any future updates will be listed below
-
Authors
Valentino, Rebecca R.
Koga, Shunsuke
Walton, Ronald L.
Soto-Beasley, Alexandra I.
Kouri, Naomi
DeTure, Michael A.
Murray, Melissa E.
Johnson, Patrick W.
Petersen, Ronald C.
Boeve, Bradley F.
Uitti, Ryan J.
Wszolek, Zbigniew K.
Dickson, Dennis W.
Ross, Owen A.
Heckman, Michael G. https://orcid.org/0000-0003-3770-9331
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U54-NS100693)
National Institutes of Health (UG3-NS104095, P50-NS072187, R01- NS078086, U54-NS100693, U54- NS110435, P50-AG016574, P01-AG003949)
U.S. Department of Defense (W81XWH-17-1-0249)
- License Information
-
More Information
Article History
Received: 26 October 2020
Accepted: 26 November 2020
First Online: 7 December 2020
Ethics approval
: This study was approved by the Mayo Clinic Institutional Review Board. All subjects or legal next of kin provided written informed consent.
: Not applicable.
: ZKW serves as Mayo Clinic Florida PI Biogen, Inc. (228PD201), Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301), and Neuraly, Inc. (NLY01-PD-1) grants. He serves as Co-PI of the Mayo Clinic American Parkinson Disease Association Center for Advanced Research. All other authors declare that they have no competing interests.
